SHLS Q1 2026 Earnings EPS Beats Estimates as Shares Gain TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage FKWL Q1 2026 Earnings Significant EPS Miss and Stock Decline AIRG Q1 2026 Earnings Mixed Results as Loss Slightly Exceeds Estimates aTyr Pharma Q1 2026 Earnings NarrowerThanExpected Loss Provides Some Relief Amid Pipeline Development SACH Q1 2026 Earnings Massive EPS Surprise Miss Drives Stock Down 25